About Bhasya International
Bhasya International is a Healthcare company. Pharmaceutical manufacturing, supplying, and exporting of APIs, excipients, and related materials in India. The company has 1 employees. Its Indian entity Bhasya International Private Limited reported revenue of ₹59.51 Cr. Bhasya International offers products and services including APIs and DC Granules. Its focus areas include Pharmaceuticals, API Manufacturing, Drug Intermediates and Logistics.
Company details
Bhasya International is recognized for its role in supplying and exporting pharmaceutical products, including active pharmaceutical ingredients, DC granules, excipients, and herbal APIs. With over 15 years of experience, operations are based in Hyderabad, India, where complete sourcing and marketing solutions are provided to clients worldwide. Logistics services are offered to ensure efficient global shipping, and the company maintains ISO 9001:2015 certification for quality in manufacturing and support services. A wide range of products is made available to meet pharmaceutical industry needs, emphasizing transparency and ethical practices.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bhasyainternational.com
- Social LinkedIn
- Legal Name Bhasya International Pvt Ltd
- Date of Incorporation 19 Aug, 2020
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹59.51 Cr
FY 2024 · +124% YoY
- Indian entity net profit₹92 Lakh
FY 2024 · 2% margin
- Indian entity EBITDA₹1.57 Cr
FY 2024 · 3% margin
- Employee Count1
Associated legal entities of Bhasya International
Bhasya International operates through Bhasya International Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bhasya International Private Limited CIN U51909TG2020PTC142949 | Active | 19 Aug 2020 | Hyderabad, Telangana | ₹59.5 Cr | 5 | View details |
Products & Services of Bhasya International
Bhasya International offers a comprehensive portfolio of products and services, including APIs and DC Granules.
Active pharmaceutical ingredients are manufactured and supplied for drug production
Directly compressible granules are provided for tablet formulation in pharmaceutical applications
Board of directors of Bhasya International Private Limited (Bhasya International)
Bhasya International Private Limited is the primary company behind Bhasya International. The board of Bhasya International Private Limited currently have 5 directors; the longest-serving is Jaya Sai Yarlagadda, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jaya Sai Yarlagadda DIN 08838984 | Director | 19 Aug 2020 | 6 yrs 2 mo | Bhasya International Private Limited |
| Sravani Koratana DIN 08838985 | Director | 19 Aug 2020 | 6 yrs 2 mo | Bhasya International Private Limited |
| Bhaskara Rao Akkapolu DIN 10408382 | Director | 12 Feb 2024 | 2 yrs 9 mo | Bhasya International Private Limited |
| Veera Basava Shivakumari Samatham DIN 10416024 | Additional Director | 12 Feb 2024 | 2 yrs 9 mo | Bhasya International Private Limited |
| Syam Kumar Kokku DIN 10408361 | Additional Director | 12 Feb 2024 | 2 yrs 9 mo | Bhasya International Private Limited |
Financials of Bhasya International
Figures of Bhasya International Private Limited, the primary company behind Bhasya International, for FY 2024. Revenue was ₹59.51 Cr (+124% year on year). Net profit was ₹92 Lakh (2% margin). EBITDA was ₹1.57 Cr (3% margin). Revenue has grown at a compounded annual rate of +545% over three years.
- ₹59.51 CrRevenue · FY 2024 · +124% YoY
- ₹92 LakhNet profit · 2% margin
- ₹1.57 CrEBITDA · 3% margin
- ₹1.30 CrPaid-up capital
- +545%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Bhasya International Private Limited are on its company page.
Detailed financial statements for Bhasya International
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bhasya International
Bhasya International has 1 employees.
The primary company behind Bhasya International, Bhasya International Private Limited, reported revenue of ₹59.51 Cr for FY 2024, up 124% year on year.
Bhasya International is recognized for its role in supplying and exporting pharmaceutical products, including active pharmaceutical ingredients, DC granules, excipients, and herbal APIs. With over 15 years of experience, operations are based in Hyderabad, India, where complete sourcing and marketing solutions are provided to clients worldwide. Logistics services are offered to ensure efficient global shipping, and the company maintains ISO 9001:2015 certification for quality in manufacturing and support services. A wide range of products is made available to meet pharmaceutical industry needs, emphasizing transparency and ethical practices.
Bhasya International offers APIs and DC Granules.
Bhasya International operates through Bhasya International Private Limited.
The legal entities of Bhasya International currently have 5 directors, including Jaya Sai Yarlagadda, Sravani Koratana, Bhaskara Rao Akkapolu and others.